Key Market Indicators
Norwegian Hormones Sales are set to reach nearly $72 million by 2026. This growth of 0.3% a year is slightly higher than the average 0.6% yearly rise since 2004. In 2021, Norway came in at 18th place, behind Ireland’s $69.83 million. Germany, the United Kingdom and Italy were the top three countries in this ranking.
